Bruker Corporation today announced that it has acquired JPK Instruments AG (JPK), located in Berlin, Germany. In 2017, JPK Instruments had revenue of approximately 10 million Euro. JPK provides microscopy instrumentation for biomolecular and cellular imaging, as well as force measurements on single molecules, cells and tissues. JPK adds in-depth expertise in live-cell imaging, cellular mechanics, adhesion, and molecular force measurements, optical trapping, and biological stimulus-response characterization to Bruker. Financial details of the transaction were not disclosed.
Over the past five years, Bruker has developed a life science microscopy business that specializes in advanced technologies for neuroscience, live-cell imaging, and molecular imaging, which will be further augmented by JPK’s advanced technologies and applications. Bruker’s existing fluorescence microscopy techniques include performance-leading multiphoton microscopy, swept-field confocal microscopy, super-resolution microscopy, and single-plane illumination microscopy.
“We have been making a substantial investment in advanced technologies for life science imaging, and have built up a portfolio of fluorescence microscopy products that enable biologists in research areas that require deep, fast imaging at high resolution and at low phototoxicity,” commented Dr. Mark R. Munch, President of the Bruker NANO Group. “JPK’s products and applications capabilities nicely augment our current techniques.”
Anthony Finbow, Chairman at JPK, added: “The combination of these two businesses will enable further significant advances in life science imaging and drive the state of the industry. I am delighted that we have been able to achieve this result for JPK and for Bruker.”
“The business we have built aligns well with the new strategic direction of Bruker in life science microscopy, and we are very pleased to join them,” said Dr. Torsten Jaehnke, a JPK founder and CTO. “We plan to realize a number of valuable synergies going forward.”